CHEN LAN BO has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are DEISHER THERESA, UBI IP HOLDINGS and IN3BIO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Taiwan | 2 | |
#6 | Canada | 1 | |
#7 | Hungary | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Serbia | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Chen Lan Bo | 22 |
#2 | Tatsuta Noriaki | 1 |
#3 | Koya Keizo | 1 |
#4 | Ono Mitsunori | 1 |
#5 | Yamaguchi Naoto | 1 |
Publication | Filing date | Title |
---|---|---|
US2018028632A1 | Method of treating tumors with nk and nkt cells expressing anti-ssea4 chimeric antigen receptors | |
US2018028633A1 | Chimeric antigen receptor combination therapy for treating tumors | |
US2018028634A1 | Method for prolonging and enhancing anti-tumor vaccine response | |
US2018028630A1 | Compositions and methods for therapeutic anti-cancer vaccination | |
US2018030123A1 | Method for treating a tumor with bifunctional agents that bind to tumor carbohydrate antigens | |
US2018030124A1 | Methods and compositions for enhancing anti-ssea4 immunotherapy | |
US2018028631A1 | Anti-ssea4 chimeric antigen receptors and their use for treating cancer | |
RS59800B1 | Composition and method for aiding sleep | |
AU2005220186A1 | Water soluble bean-based extracts |